These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1700756)

  • 1. Polarity of immunogens: implications for vaccine design.
    Golvano J; Lasarte JJ; Sarobe P; Gullón A; Prieto J; Borrás-Cuesta F
    Eur J Immunol; 1990 Oct; 20(10):2363-6. PubMed ID: 1700756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential order of T and B cell epitopes affects immunogenicity but not antibody recognition of the B cell epitope.
    Denton G; Hudecz F; Kajtár J; Murray A; Tendler SJ; Price MR
    Pept Res; 1994; 7(5):258-64. PubMed ID: 7531518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
    Olszewska W; Obeid OE; Steward MW
    Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides.
    Partidos C; Stanley C; Steward M
    Eur J Immunol; 1992 Oct; 22(10):2675-80. PubMed ID: 1382995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
    Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC
    J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic vaccine constructed by copolymerization of B and T cell determinants.
    Leclerc C; Przewlocki G; Schutze MP; Chedid L
    Eur J Immunol; 1987 Feb; 17(2):269-73. PubMed ID: 2435562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria vaccine: immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity.
    Migliorini P; Betschart B; Corradin G
    Eur J Immunol; 1993 Feb; 23(2):582-5. PubMed ID: 7679652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable epitope library-based vaccines: shooting moving targets.
    Pedroza-Roldan C; Charles-Niño C; Saavedra R; Govezensky T; Vaca L; Avaniss-Aghajani E; Gevorkian G; Manoutcharian K
    Mol Immunol; 2009 Dec; 47(2-3):270-82. PubMed ID: 19853920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase.
    Reynolds SR; Dahl CE; Harn DA
    J Immunol; 1994 Jan; 152(1):193-200. PubMed ID: 7504709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering of immunogenic peptides by co-linear synthesis of determinants recognized by B and T cells.
    Borras-Cuesta F; Petit-Camurdan A; Fedon Y
    Eur J Immunol; 1987 Aug; 17(8):1213-5. PubMed ID: 2442000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
    Ahlers JD; Pendleton CD; Dunlop N; Minassian A; Nara PL; Berzofsky JA
    J Immunol; 1993 Jun; 150(12):5647-65. PubMed ID: 8515081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with a peptide having both T cell and conformationally restricted B cell epitopes elicits neutralizing antisera against a snake neurotoxin.
    Léonetti M; Pillet L; Maillère B; Lamthanh H; Frachon P; Couderc J; Ménez A
    J Immunol; 1990 Dec; 145(12):4214-21. PubMed ID: 1701784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of different presentation strategies for an HIV peptide immunogen.
    Cruz LJ; Iglesias E; Aguilar JC; González LJ; Reyes O; Albericio F; Andreu D
    Bioconjug Chem; 2004; 15(1):112-20. PubMed ID: 14733590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the T cell response to two allelic forms of a malarial vaccine candidate protein.
    Rzepczyk CM; Csurhes PA; Saul AJ; Jones GL; Dyer S; Chee D; Goss N; Irving DO
    J Immunol; 1992 Feb; 148(4):1197-204. PubMed ID: 1371134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional heterogeneity of memory B lymphocytes: in vivo analysis of TD-primed B cells responsive to secondary stimulation with TD and TI antigens.
    Rennick DM; Morrow PR; Benjamini E
    J Immunol; 1983 Aug; 131(2):561-6. PubMed ID: 6190934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
    J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1.
    Udhayakumar V; Anyona D; Kariuki S; Shi YP; Bloland PB; Branch OH; Weiss W; Nahlen BL; Kaslow DC; Lal AA
    J Immunol; 1995 Jun; 154(11):6022-30. PubMed ID: 7538540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fully synthetic immunogens. Part III. Synthesis of hinge-peptide/gastrin conjugates and their immunological properties.
    Wünsch E; Moroder L; Hübener G; Musiol HJ; Von Grünigen R; Göhring W; Scharf R; Schneider CH
    Int J Pept Protein Res; 1991 Feb; 37(2):90-102. PubMed ID: 1708369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards the design of heterovalent anti-malaria vaccines: a hybrid immunogen capable of eliciting immune responses to epitopes of circumsporozoite antigens from two different species of the malaria parasite, Plasmodium.
    Kironde FA; Rao KV; Shah S; Kumar A; Sahoo N
    Immunology; 1991 Oct; 74(2):323-8. PubMed ID: 1721043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.